December 9, 2016

“We advise the public to be cautious when reviewing [adverse event] reports and to consider the fuller picture,” CRN cautioned.

December 8, 2016

As part of an agreement with the DOJ, GNC will take a number of actions to broaden industry-wide knowledge of prohibited ingredients and improve compliance by vendors of third party products.

December 7, 2016

President Obama said in his Dec. 3 weekly address that he would sign the legislation into law "as soon as it reaches my desk."

December 7, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of automation and technology, in this multi-page report.

December 7, 2016

The FDA has cited that hearing loss affects some 30 million people in the United States and can have a significant impact on communication, social participation and overall health and quality of life.

December 7, 2016

NCPA addressed several areas where independent community pharmacies and the patients they serve could be adversely affected by the pharmacy “lock-in” provision in the opioid abuse legislation.

December 6, 2016

Drug Store News caught up with NACDS president and CEO Steve Anderson for a recap of 2016 and a look ahead at what to expect from a Trump administration.

DSN: What is the RxImpact scorecard for 2016? How did the industry do on the key pharmacy and patient access issues?

December 6, 2016

The bottom line behind President-elect Donald Trump’s proposals: The cost burden of the $3 trillion industry will shift away from the federal government and toward private enterprise, state government and consumers.

December 5, 2016

Schloss is an experienced and accomplished executive with two decades of experience in federal government affairs, most recently at Mylan helping direct their Congressional outreach efforts.

December 5, 2016
The Food and Drug Administration’s director of the Center for Drug Evaluation and Research, Dr. Janet Woodcock, said that the agency would conduct a national search to fill the vacancy left by retiring Office of New Drugs director Dr. John Jenkins, and that in the interim, she would be acting director of the OND.
December 5, 2016

The U.S. House of Representatives passed the final NDAA Dec. 2– as negotiated between the House and Senate. Senate passed the action a week later on Dec. 8.

December 2, 2016

SimplECG collects continuous multi-channel ECG, heart rate and respiratory rate data from the garment and transfers it to a web-based portal for review by a physician, by way of a mobile application.

December 2, 2016

TRICARE serves 9.5 million patients all told, including Active Duty Service members, National Guard and Reserve members, retirees, their families, survivors and certain former spouses worldwide.

December 1, 2016

CRN's Steve Mister is one of six new members recently welcomed to the C100. According to Mister, the C100 provides CRN with new opportunities to collaborate.

December 1, 2016

According to the CVS Health poll, 26% of respondents admitted they put off needed medical care in the past month because of high costs.

November 29, 2016

The retail pharmacy industry is "enthusiastic to help leverage pharmacy to improve Americans’ health and well-being," NACDS president and CEO Steven Anderson noted regarding Trump's health nominations. "NACDS has a powerful story to tell."

November 29, 2016

GPhA president and CEO Chip Davis called for passage of the 21st Century Cures Act, which is headed to the House of Representatives this week, citing its funding for an act that would work to address the prescription drug abuse epidemic.

November 22, 2016

Presidential election of Donald Trump not the only thing to look at beginning in 2017.

November 16, 2016

Meter manufacturers today are differentiating their offerings with an accompanying adherence app or other technologies that will help diabetes patients better navigate their disease states.

November 16, 2016

Biosimilars are expected to save the healthcare system between $44 billion and $250 billion in the next 10 years.

November 16, 2016

Aurobindo has introduced a new label design as the company continues to eclipse market growth predictions, most recently moving into the Top 6 among all generic companies in prescriptions dispensed, according to QuintilesIMS National Prescription Audit data from August.

November 16, 2016

The Generic Drug User Fee Agreement, enacted under the Food and Drug Administration Safety and Innovation Act of 2012, has generated some $1.5 billion in user fees and has seen 1,992 approvals issued.

November 16, 2016

Generic medications saved the U.S. healthcare system more money in 2015 than ever before, according to the eighth-annual “2016 Generic Drug Savings & Access in the United States Report,” compiled by Quintiles IMS Institute on behalf of the Generic Pharmaceutical Association. This year’s report found $227 billion saved by using generics in 2015.

November 15, 2016

The NACDS Foundation has continued to advance its mission this year through several vital initiatives, including a collaborative response to the Zika virus public health emergency with the CDC and the CDC Foundation.